Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience

Background: Increasing evidence indicates a relationship between systemic inflammation and survival following treatment in various tumors. However, the correlation of systematic inflammation with survival after stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCL...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Luo, Hui, Ge, Hong, Cui, Yingying, Zhang, Jiangong, Fan, Ruitai, Zheng, Anping, Zheng, Xiaoli, Sun, Yanan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2018
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743726/
https://ncbi.nlm.nih.gov/pubmed/29290784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.21703
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia